Our Branding Identity

Our Partners

Our Innovation

SPC Community Responsibility

Manufacturing Site

Inspiration for Sudair Pharma brand design start with the company name

Sudair

A historical region in Najd in the central of Saudi Arabia and the palm tree that Sudair region famous with it (like most others in Najd).

The palm tree

symbolizes achievement, expansion and durability, at the same time it′s a sign of munificence and cure in many cultures of the Middle East.

OUR CONCEPT INSPIRED FROM

Durable

(Resisting difficulties)

Diffusion

(Spreading hope)

Expand

(Reach out to cover KSA, MENA and rest of the world)

Medicine

(establishing and localizing advanced pharmaceutical biologics industrial group).

AS A COLLECTIVE PICTURE FROM ALL THE PERVIOUS INSPIRATIONAL CONCEPTS,

WE CREATED OUR UNIQUE LOGO TO BE:

The right side parts more loose than the other sides, that aims to reach out to all targeted regions

OUR PARTNERS

PARTNERING STRATEGY

Collaborating with global partners to provide a richer portfolio of medicines for our patients through licensing deals.

Creating long term partnerships with multinational pharmaceutical companies built on various business models.

Overview

Novartis has been working in Saudi under official operation with legal entity since early 70’s in the name of Novartis’s parent’s former companies (Ciba, Giegy, Sandoz and Zyma and) whom merged into one entity named Novartis through our early 90’s, yet some other group members of companies to join the group like Alcon. Today Novartis in Saudi operates as multi-divisional experts in different clusters of disease areas and it was the first pharmaceutical model of foreign investment law under MISA .Novartis operates businesses with global scale and strong customer ties, focusing on innovative patented medicines, generics and eye care.

Mission and Vision

Our mission is to discover new ways to improve and extend people’s lives. Our vision is to be a trusted leader in changing the practice of medicine & to help in reducing disease burden and improve quality of lives of patients inside Saudi Arabia.

Our Values

Strong values define our culture and help us execute the Novartis strategy in line with our mission and vision: Collaboration, Performance, Quality, Innovation, Integrity, and Courage.

Our Business
Novartis Pharmaceuticals:

Commercializes innovative, patented primary care and specialty medicines to enhance health outcomes for patients and health-care providers in : Cardio-Metabolic Disease – Neuroscience – Ophthalmology - Respiratory & Dermatology

Novartis Oncology:

Commercializes a portfolio of patented oncology, hematology and rare disease medicines to address the medical needs of people with cancer and related diseases.

Sandoz

is a global leader in generic pharmaceuticals and biosimilar that pioneers novel approaches to help people around the world access high-quality medicines.

Other activities:
Novartis Saudi Arabia is driving a strategy of active participation in Saudi health care system and economy via different initiatives of collaboration with Government and local industry aiming to transfer technologies, local production and co-manufacturing. Novartis Saudi Arabia also implements social corporate responsibility initiatives based on our sense of responsibility toward Saudi community. These initiatives are orbiting around social awareness and contribution of values and non commercial services.

  • Dr. Reddy’s Laboratories is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. For more information, log on to: www.drreddys.com.

  • BIOCAD is Russia's leading innovative biotechnology company; it combines a world-class research and development center, ultra-modern pharmaceutical and biotechnological manufacturing facilities, as well as preclinical and clinical research infrastructure compliant with international standards.
  • BIOCAD is one of the world`s few full-cycle drug development and manufacturing companies, from new molecule discovery and genetic engineering to large-scale commercial production and marketing support.
  • BIOCAD`Smedicines are dedicated to treat complex health conditions such as cancer, HIV and Hepatitis C infections, multiple sclerosis and other disorders.
  • Our mission is increasing life expectancy and improving quality of life
  • We are an international innovative biotech company that combines a world-class research center with modern pharmaceutical production, as well as preclinical and clinical studies compliant with international standards
  • The core of our business is combining creativity and professionalism in solving problems. Patience and painstaking hard work is our formula for successful achievement of our goals.
  • Our business is based on the accumulation of advanced knowledge, which enables us to unlock the revolutionary potential for creating optimal conditions for patients to live happier lives

  • A public shareholding company established in 1975, headquartered in Na’ur and Amman, Jordan.
  • Fully integrated pharmaceutical company Specialized in the development, manufacturing, marketing and distribution of high quality branded generic pharmaceutical and consumer health care products.
  • Our products cover main therapeutic areas.
  • Global presence: Dedicated staff of over 900 people in more than 30 countries throughout the Middle East, Africa and Europe.
  • Manufacturing Sites: 4 plants in Jordan and 1 in Algeria

  • Founded in 2003, the Hyderabad based MSN Labs is one of the fastest growing research-based pharmaceutical company in India. Boasting a diverse product portfolio, with multiple products in the market and in the pipeline, MSN has 9 API and 5 Finished Dosage facilities (including Oncology) and an integrated R&D Centre.
  • Innovation & speed form the core of our business strategy. Pro-active marketing, innovative R&D expertise, insight driven IT and world class capabilities are our ingredients to success.
  • With a dedicated & experienced team of over 6000, the work environment at MSN integrates multiple disciplines and functions by exhaustive communication of goals and objectives through technology and values of Integrity, Imagination & Innovation.
  • With an outstanding workforce, cutting-edge science, state-of-the-art technology and knowledge intensive initiatives, we are working on innovative solutions for tomorrow`s healthcare challenges.

  • in 1935 Cipla Limited is a global pharmaceutical company established in Mumbai - India, the company uses technology and innovation to meet the everyday needs of all patients. For more than 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 80+ countries. Our portfolio includes over 1500 products with 50+ dosage forms across wide range of therapeutic categories.
  • They started in the US market in 1984, when Cipla became the first Indian company to receive US FDA approval. Today in a tightly regulated , Cipla's 45+ manufacturing facilities across India have been approved by major international regulatory agencies including US FDA, MHRA-UK, WHO, Department of Health-Canada, MCC – South Africa, ANVISA – Brazil, and PMDA – Japan. Cipla maintains world-class quality for its products and services across domestic and overseas markets, thereby ensuring that every patient has access to the best medicines in the world.

QUALITY BEYOND COMPLIANCE

SPC is ethically bound to the development of quality products apart from its legal obligations.

In doing so it has adopted SFDA, US-FDA, EU, PICs, WHO, ISO standards and in terms of current Good Manufacturing Practices (cGMP), current Good Laboratory Practices (cGLP), and International Conference for Harmonization (ICH) guidelines. Further it also develops its own standards to ensure that the products consistently meet the predefined standards.
Quality is embedded in every aspect of our business, and the way we support our internal and external customers. From product development, and through manufacture to distribution process, we ensure our quality standards are met.
SPC has developed and sustained a strong position in Saudi Arabia in terms of growth, serving export markets and a preferred partner in local and international alliances.

SPC plant utilizes state-of-the-art technologies in order to manufacture safe and effective high-quality medicinal products. Heavy investment in advanced machinery/technology has served in efficiency in product life cycle and supply-chain management.

SPC is committed to protect its employees as well as the environment. The company relies on the participation of all employees on the continuous improvement of the Quality, Health, Safety and Environmental Management System (QHSE).

SPC adapt Quality Management System (QMS) is focused on achieving quality policy and quality objectives to meet the regulatory and customer requirements. The QMS is being maintained and monitored using electronic record that improves the workflow within the quality system.

Enterprise Resource Planning (ERP) – SAP, streamline business application and provide a high degree of confidence on managing critical quality/GMP processes.

Quality Assurance unit in SPC, ensures that quality systems are implemented, maintained, followed and improved. Line inspection provides assurance that the manufactured products follow the pre-determined in-process specifications and comply with its standards. The environmental conditions are being monitored and qualified. The water system is qualified to assure compliance with the regulations and standards.

Validation is an integral part of the quality system wherein it provides documented evidence with a high degree of assurance that a process, method or system will consistently produce to the required specification in accordance with accepted standards of cGMP and local or international regulations.

Quality Control activities cover all measures taken into the final product, including the setting of specifications, sampling, testing and analytical method to ensure that raw materials, intermediates, packaging materials and finished products comply with established specifications for identity, strength, purity and other characteristics.

Quality improvements are being accounted by undertaking good compliance program that assures strict adherence to the policies and principles of SPC Integrated Quality Management System.

SPC HAS BEEN AWARDED WITH THE FOLLOWING CERTIFICATION

CERTIFICATE

Of GMP Compliance of a Manufacturer from the Saudi Food and Drug Authority (SFDA).

CERTIFICATE

Of GMP Compliance of a Manufacturer from (GCC).

SPC Community Responsibility


  • Training
  • Scientific Societies
  • Patient supporting societies
  • Patient awareness role

SPC has collaborated with King Saud University and Princess Nora University to conduct internship program for senior pharmacy students.

In August 2020, SPC has started the first summer training program for pharmacy students with a program that designed to help the students to build their capabilities and give them an example of the real working life. Help students in deciding the kind of specialization they want to pursue, learn and Interact with Industry Experts.

We are supporting scientific Saudi societies as a part of our community role to support the continuous learning role for all health care providers in KSA and GCC.

SSBD

The Saudi Society for Blood Disorders (SSBD) is a professional non-profit organization, founded according to Saudi Commission for Health Specialties (SCFHS) associations council recommendation and based on agreement letter number 1/A/2018 dated 30 May 2018 of Board of Trustees of SCFHS headed by the Minister of Health.

SSBD

SLCA

The Saudi Lung Cancer Association is a group under the Saudi Thoracic Society. SLCA aims to collaborate and lead national and international initiatives in lung cancer control including prevention, education, research, and promotion of evidence- based practice.

SLCA

SSBMT

It is a professional non-profit organization. The Society aims to promote the advancement in management of the blood and marrow transplantation and related blood and cancer diseases. The Society represents multiple medical and scientific disciplines such as hematology, oncology, immunology, genetics, microbiology, pediatrics, and internal medicine.

SSBMT

OSH

The Omani Society of Hematology (OSH) is a professional organization committed towards excellence in professional development in Hematological disorders.

Oman Society of Hematology

SOS

Saudi Oncology Society is committed to advancing education of oncologists and other oncology professionals. fostering communication among cancer-related medical subspecialties and the exchange of a wide range of ideas related to cancer.

SOS

EOC

The Emirates Oncology Society is dedicated to promoting and fostering the multidimensional care of cancer patients throughout the United Arab Emirates, by bringing together all of the practicing cancer specialists across all disciplines.

Emirates Oncology Society

SPC believe of the pharmaceutical companies in serving the community and as a part of our role we work closely with patients supporting societies like but not limited to:

  • SAND سند
  • Amass جمعية أمسّ
  • ENAYAH عناية
  • جمعية مكافحة السرطان

Awareness of the patients is one of the most important roles for SPC to increase their level of knowledge about different diseases either on the way how they can deal with the disease or how to prevent themselves from these diseases , on SPC we are regularly publish a scientific materials that can help on disseminating the knowledgeable information that is balanced and medically reviewed , like :

  • Breast Cancer Days
  • Colorectal Cancer Days
  • Prostate Cancer Days
  • Leukemia Days

SPC QUALITY

“Quality Beyond Compliance”

SPC is ethically bound to the development of quality products apart from its legal obligations. In doing so it has adopted SFDA, US-FDA, EU, PICs, WHO, ISO standards and in terms of current Good Manufacturing Practices (cGMP), current Good Laboratory Practices (cGLP), and International Conference for Harmonization (ICH) guidelines. Further it also develops its own standards to ensure that the products consistently meet the predefined standards.

Quality is embedded in every aspect of our business, and the way we support our internal and external customers. From product development, and through manufacture to distribution process, we ensure our quality standards are met.

SPC has developed and sustained a strong position in Saudi Arabia in terms of growth, serving export markets and a preferred partner in local and international alliances.

SPC plant utilizes state-of-the-art technologies in order to manufacture safe and effective high-quality medicinal products. Heavy investment in advanced machinery/technology has served in efficiency in product life cycle and supply-chain management.

SPC is committed to protect its employees as well as the environment. The company relies on the participation of all employees on the continuous improvement of the Quality, Health, Safety and Environmental Management System (QHSE).

SPC adapt Quality Management System (QMS) is focused on achieving quality policy and quality objectives to meet the regulatory and customer requirements. The QMS is being maintained and monitored using electronic record that improves the workflow within the quality system.

SPC HAS BEEN AWARDED

With The Following Certification

CERTIFICATE of GMP Compliance of a Manufacturer from (GCC).

CERTIFICATE of GMP Compliance of a Manufacturer from the Saudi Food and Drug Authority (SFDA).

R&D CAPABILITIES

Is led by highly specialized, skilled and qualified team of professionals, equipped with sophisticated devices where they scientifically handle formulation, process and analytical development of high quality products complying with SFDA and international requirements and standards.

Full technology transfer

Product formulation

Trouble shooting

Stability studies

Process design & validation

Management of bio-equivalency studies

Creation of the e-CTDs for developed products

Analytical development and validation activities